EpiVax, Inc. - Informatics and Immunology
  • Our Company
    • Company Overview
    • Corporate Responsibility
    • Mission, Vision & Values
    • Team
    • Careers
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • BioDefense Vaccines
    • Tregitope: Immunomodulation Power Tool
    • Deimmunization Projects
  • Vaccine Services
    • Vaccine Services
    • iVAX: Web-based Vaccine Design
    • PreVAX Analysis
    • EpiCC
  • Immunogenicity Assessment
    • Immunogenicity Assessment Overview
    • ISPRI Web-based Immunogenicity Assessment
    • PreDeFT Analysis
    • High Throughput Immunogenicity Analysis
    • PANDA Screening
    • ISPRI for Host Cell Proteins
    • Deimmunization
    • Trusted Expert Advice (TEA) Consulting Services
  • Lab Services
    • Lab Services Overview
    • HLA Binding Assays
    • T Cell Assays
  • Press Room
    • Press Room
    • Events
      • Webinars
    • Publication & Poster Search
    • Client Testimonials
    • Thinking Out Loud (Blog)
    • Recipes For Success (Podcast)
  • Contact Us
Select Page
Hey Hey! Hallo! This is a two-way conversation!

Hey Hey! Hallo! This is a two-way conversation!

by Elena Iemma | Nov 27, 2023 | Featured, Thinking Out Loud -Blog

This is a two-way street Hey Hey, Hallo, Hola, Ciao, Namaste, Hello, Bonjour, Konnichiwa! When do you do your ‘thinking’ about the day? Do you do it while running? Well, I was thinking about you guys on my runs this week. I am finally back in Providence,...
EpiVax CEO Speaks at the Hwasun International Vaccine and Immunotherapy Forum

EpiVax CEO Speaks at the Hwasun International Vaccine and Immunotherapy Forum

by Elena Iemma | Nov 20, 2023 | Featured, News

EpiVax CEO Annie De Groot was one of three plenary session speakers at a recent international forum on vaccines organized by Joon Rhee. Her topic was ‘Better, Safer, and Personalized Vaccines will Result from Human + Artificial Intelligence’. Other speakers...
Visits from the FBI and SEC… and Fearless Science

Visits from the FBI and SEC… and Fearless Science

by Elena Iemma | Nov 2, 2023 | Thinking Out Loud -Blog

See you in Munich… or Amsterdam! Before we get to the scary stuff, have you registered for the 9th annual Amsterdam Immunogenicity and Tolerance Seminar yet? We have an amazing line up of talks planned (see details here). A range of speakers from Cardiff and the...
Dreaming of Peptides (and Hello from Tokyo!)

Dreaming of Peptides (and Hello from Tokyo!)

by Elena Iemma | Sep 25, 2023 | Thinking Out Loud -Blog

Welcome to Tokyo! Yes! it’s true! – we’re in Tokyo! Sarah Moniz, Guilhem Richard (CTO of EpiVax Therapeutics) and I touched down on Friday and have been checking out Tokyo landmarks (aka lots of walking) over the weekend. We are beyond thrilled to...
Streamlining Generic Drug Immunogenicity Evaluation:  EpiVax’s “PANDA” Approach

Streamlining Generic Drug Immunogenicity Evaluation: EpiVax’s “PANDA” Approach

by Elena Iemma | Aug 10, 2023 | Featured, News

PROVIDENCE, RI, August 10, 2023 /PRNewswire/ — EpiVax Inc. announces the publication of results from a research collaboration with the Food and Drug Administration aimed at streamlining generic drug evaluations. The research, initiated in 2018 with a $1M...
« Older Entries

Recent Posts

  • Hey Hey! Hallo! This is a two-way conversation!
  • EpiVax CEO Speaks at the Hwasun International Vaccine and Immunotherapy Forum
  • Visits from the FBI and SEC… and Fearless Science
  • Dreaming of Peptides (and Hello from Tokyo!)
  • Streamlining Generic Drug Immunogenicity Evaluation: EpiVax’s “PANDA” Approach

Categories

  • EpiVax Immunoncology
  • Events
  • Featured
  • News
  • Recipes for Success – Vlog
  • Thinking Out Loud -Blog
  • Uncategorized
  • Webinars

Discover

  • Vaccine Services
  • Immunogenicity Assessment
  • Deimmunization
  • Lab Services
  • Pipeline

About

  • Our Company
  • Press Room
  • Events
  • Publication & Poster Search
  • Thinking Out Loud (Blog)
  • Contact Us

Connect

© 2023 EpiVax, Inc. – Informatics and Immunology, All rights reserved. Privacy Policy • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 • fax: 401.272.7562